Contact
Please use this form to send email to PR contact of this press release:
ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
TO:
Please use this form to send email to PR contact of this press release:
ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
TO: